Dominic Piscitelli, Chief Financial Officer at Oric Pharmaceuticals, Inc. (ORIC), bought 60,000 shares at $5.36 ($322K) on 2022-03-31, disclosed to the SEC on 2022-03-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ORIC | SELL | 2026-02-26 | $703K | — | Filing → |
| ORIC | SELL | 2025-12-17 | $194K | — | Filing → |
| ORIC | SELL | 2025-10-08 | $160K | — | Filing → |